Posters

13 Patient-specific cancer vaccine of cultured autologous tumor cells and autologous dendritic cells
RO Dillman, PM Schiltz, R Selvan, C de Leon, C Peterson, K Spencer, A Beatty, C DePriest, LD Beutel
Hoag Cancer Center, Newport Beach, CA
14 Dendritic cells loaded with melanoma cell lysate induce T cell responses against melanoma shared antigens in vitro and in melanoma patients
Duffour MT1, Nardin A1, Boccaccio Claire1, Bercovici N1, Massicard S1, Pauillac F1, Agrawal S1, Prigent D1, Goxe B1, Latour N1, Heshmati F3, Duriau D2, Lehmann F2, Bruyns C2, Velu T2, Salcedo M1, Abastado JP11Immuno Designed Molecules (IDM) Paris, France; 2Erasme Bordet Medical Oncology, ULB Brussels, Belgium; 3Hopital Cochin, Paris, France
15 Tumor Necrosis Therapy Antibody/Cytokine Fusion Proteins for the Immunotherapy of Solid Tumors of the Mouse
Peisheng Hu, Jiali Li, Myra Mizokami, Leslie Khawli, and Alan L. Epstein
Department of Pathology, USC Keck School of Medicine, Los Angeles, CA
16 Effects of ABX-EGF, A Fully Human Anti-EGFr Antibody, in Patients with Advanced Cancer
R. Figlin1, A. Belldegrun1, J. Crawford2, M. Lohner3, L. Roskos3, X-D. Yang3, K. Foon3, G. Schwab3, L. Weiner41University of California Los Angeles, 2Duke University, 3Abgenix Inc, 4Fox Chase Cancer Center
17 Modulation of Dendritic Cell Function by Extracoroporeal Phototherapy in Patients with Chronic Graft-vs-Host Disease is Associated with Clinical Response
Foss, Francine; Gorgun, Gullu; Alcindor, Thierry
Hematology Oncology, Tufts New England Medical Center Boston, MA
18 Comparison of Dendritic Cells Generated from Patients Primed with GM-CSF or G-CSF versus Unprimed Patients
Garlie, Nina; Aoys, Eric; Lefever, Ann
Immunotherapy Program, St. Luke’s Medical Center Milwaukee, WI
19 Eradication of pancreatic ductal adenocarcinoma cells and lymphatic/vascular endothelial cells by induction of D2 apoptotic stage leading to bystander killing effect after treatment with rhuMAb KDR/Flk-1(VEGFR-2) linked onto pegylated liposomal VRL (PLVT)
Giannios J, Michailakis E
Clinical Oncology, General State Hospital of Athens
20 Interleukin (IL)-12 Augments Monocyte IL-18 Binding Protein (IL-18BPa) Gene Expression via Interferon (IFN)-g
Gollob JA, Veenstra KG
Beth Israel Deaconess Medical Center, Boston, MA
21 Heavy Chain Ferritin Activates Immunoregulatory T Cells by Induction of Changes in Antigen Presenting Cells
Christian P. Gray, Peter Hersey
Department of Oncology and Immunology, Newcastle Mater Misericordiae Hospital, Newcastle, Australia
22 T cells specific for cells deficient in antigen presentation – a novel tool in immunotherapy
Grufman P1, van Hall T2, Fredriksson V1, Andersson K1, Laban S2, Offringa R2, Melief CJM2 and Wolpert E11MTC, Karolinska Institutet, Stockholm, Sweden; 2Leiden University Medical Center, Leiden, The Netherlands
23 Induction of mouse renal cell cancers by streptozotocin in Mice: Adaptation to orthotopic transplant, metastatic potential, immunogenicity and response to biological therapy
M. Eilene Gruys, Timothy C. Back, Jeff Subleski, Theresa A. Wiltrout, Jong-Keuk Lee, Laura Schmidt, Morihiro Watanabe, Roscoe Stanyon, Lynnette Shorts, Jerrold M. Ward, Jon M. Wigginton, and Robert H. Wiltrout
LEI, Experimental Therapeutics Section, NIH, Center for Cancer Research, Frederick, MD
24 Glioblastoma-secreted IL-8 contributes to chemotaxis and survival of neutrophils and facilitates tumor growth in vitro
D.O. Halverson¹, M. Martins-Green², R. Salcedo³, J.J. Oppenheim³ and W.J. Murphy¹
¹IRSP;, SAIC Frederick, Frederick, MD; ²Department; of Biology, University of California, Riverside, CA; ³Laboratory; of Immunoregulation, NCI Frederick, Frederick, MD